Camptosar is a pharmaceutical raw material that serves as an active pharmaceutical ingredient. It is a salt- and hydrate-form compound with a complex polycyclic structure.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 136572-09-3
Irinotecan
pharmaceutical raw material
Irinotecan hydrochloride
pharmaceutical raw material
Cyclopropanecarboxamide, N-[[[(1R,2R)-2-[[4,4-difluoro-4-(3-hydroxy-2-quinoxalinyl)-2-buten-1-yl]oxy]cyclopentyl]oxy]carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-2-(difluoromethyl)-N-[(1-methylcyclopropyl)sulfonyl]-, cyclic (1→2)-ether,
pharmaceutical raw material
(RS)-nefopam
pharmaceutical raw material
Sulfuric acid--{(4S)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-1-en-1-yl}methanol (1/2)
pharmaceutical raw material
Iobitridol
pharmaceutical raw material
[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;trihydrate;hydrochloride
KLEAIHJJLUAXIQ-JDRGBKBRSA-N
CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.O.O.O.Cl